New genes and models for inflammatory bowel disease

炎症性肠病影响着全世界数百万人，并造成了重大的经济负担（澳大利亚每年1亿美元）。与澳大利亚最大的生物技术公司CSL合作，我们将使用一种新的方法来发现炎症性肠病的原因。这项工作将导致炎症性肠病的新动物模型的发展，这对于分析疾病和测试治疗方案至关重要。此外，这项工作可能会导致治疗这种疾病的新方法。该项目将加深对炎症性肠病的了解，培训高技能的科学家，并可能产生具有经济价值的知识。

Inflammatory bowel disease affecting millions of people world-wide and results in a significant economic burden ($100M in Australia per year). In collaboration with Australia’s largest biotechnology company, CSL, we will use a novel approach to discover the causes of inflammatory bowel disease. This work will lead to the development of new animal models of inflammatory bowel disease that are vital for analysing the disease and testing treatment options. In addition, this work may lead to new approaches to treating this disease. The project will result in a greater understanding of inflammatory bowel disease, the training of highly skilled scientists and potentially lead to economically valuable knowledge.